Condition (MeSH)
Pemphigoid, Benign Mucous Membrane
ClinicalTrials.gov lists 16 trials for Pemphigoid, Benign Mucous Membrane or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
16 of the 16 trials are tagged with Pemphigoid, Benign Mucous Membrane itself; the rest are tagged with a narrower condition beneath it.
When did Pemphigoid, Benign Mucous Membrane trials start? (10)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 2/3
- Not applicable
- Observational
- Expanded access
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 2 |
| 2022 | 1 |
| 2020 | 3 |
| 2018 | 1 |
| 2016 | 2 |
| 2014 | 2 |
| 2012 | 1 |
| 2011 | 1 |
| 2006 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 16 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Pemphigoid, Benign Mucous Membrane trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 1/2 | 3 |
| Phase 2 | 2 |
| Phase 2/3 | 1 |
| Not applicable | 2 |
| Observational | 5 |
| Expanded access | 2 |
How many Pemphigoid, Benign Mucous Membrane trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 3 |
| Available | 2 |
| Completed | 4 |
| Terminated | 1 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Pemphigoid, Benign Mucous Membrane trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Regeneron Pharmaceuticals | 1 |
Which drugs are being tested for Pemphigoid, Benign Mucous Membrane? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| RITUXIMAB | 1 |
| INFLIXIMAB | 1 |
| Mycophenolate | 1 |
Interventions as named in the registry (10)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| cultivated oral mucosal epithelial sheet transplantation | 1 |
| large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | 1 |
| dexamethasone 0.5mg/5ml solution in Mucolox™ | 1 |
| Adalimumab-US | 1 |
| Baricitinib 2 MG [Olumiant] | 1 |
Showing 5 of 10 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Pemphigoid, Benign Mucous Membrane trials report? (2)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Anaphylaxis | 1 | 1 |
| Malignancy | 1 | 1 |
Which publications cover Pemphigoid, Benign Mucous Membrane? (21)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Efficacy and safety of a bioadhesive gel containing propolis extract, nanovitamin C and nanovitamin E on desquamative gingivitis: a double-blind, randomized, clinical trial. | Clinical oral investigations | 2023 | Yes |
| Intravenous immunoglobulin as clinical immune-modulating therapy. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne | 2015 | Yes |
| Periodontal status in oral mucous membrane pemphigoid: initial results of a case-control study. | Oral diseases | 2011 | Yes |
| Mycophenolate mofetil for ocular inflammation. | American journal of ophthalmology | 2010 | Yes |
| Methotrexate for ocular inflammatory diseases. | Ophthalmology | 2009 | Yes |
Showing 5 of 21 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.